Abstract:Background. Co-stimulatory molecules are pivotal for T cell activation. It is increasingly recognized that programmed death ligand 1 (PD-L1) is a novel costimulatory molecule, which raises the question as to whether PD-L1 regulates T cell responses. This study aimed to investigate the inhibitory effects of PD-L1 on T cell activation. Materials and Methods. We constructed a transgenic vector containing the complete PD-L1 gene, which interacts with the inhibitory receptor PD-1 in T cell-mediated immune activation. Donor dendritic cells (DCs) derived from C57BL/6 mice were transfected with PD-L1 and mixed with allogeneic, recipient T cells from BALB/c mice. The T cell activation was determined by the MTT assay and T cell proliferation was determined using carboxyfluoroscein succinimidyl ester (CFSE)-labeling following in vitro mixed leukocyte reactions. Results. The expression of PD-L1 protein in PD-L1-transfected DCs was 47.97% +/- 1.06%, compared with 4.66% +/- 0.76% and 5.30% +/- 0.60% in blank and negative controls, respectively (P < 0.05). PD-L1 protein was effectively expressed in DCs. Furthermore, in DCs stably transfected with PD-L1, T cell activation was significantly suppressed and T cell proliferation rate was decreased by 35% compared with untransfected DCs (P < 0.05). Conclusion. PD-L1 delivers an immunoinhibitory signal, suppressing T cell activation. Overexpression of PD-L1 signaling induces tolerance, which presents a promising immunotherapeutic approach for long-term graft acceptance. (C) 2012 Elsevier Inc. All rights reserved.

The ubiquitin ligase Peli1 negatively regulates T cell activation and prevents autoimmunity

Ubc13 maintains the suppressive function of regulatory T cells and prevents their conversion into effector-like T cells

Ash1l and lnc-Smad3 coordinate Smad3 locus accessibility to modulate iTreg polarization and T cell autoimmunity

Otud7b facilitates T cell activation and inflammatory responses by regulating Zap70 ubiquitination

Peli1 Negatively Regulates Noncanonical NF-κB Signaling to Restrain Systemic Lupus Erythematosus.

PELI2 Regulates Early B-cell Progenitor Differentiation and Related Leukemia Via the IL-7R Expression.

The ubiquitin ligase Stub1 negatively modulates regulatory T cell suppressive activity by promoting degradation of the transcription factor Foxp3

PDCD5 negatively regulates autoimmunity by upregulating FOXP3+ regulatory T cells and suppressing Th17 and Th1 responses

The Mediator Subunit Med23 Contributes to Controlling T-cell Activation and Prevents Autoimmunity

E3 Ubiquitin Ligase Vhl Regulates Hypoxia-Inducible Factor-1 Alpha To Maintain Regulatory T Cell Stability And Suppressive Capacity

Essential role of the E3 ubiquitin ligase Cbl-b in T cell anergy induction.

Selective Degradation of PU.1 During Autophagy Represses the Differentiation and Antitumour Activity of TH9 Cells.

Biology of Pellino1: a potential therapeutic target for inflammation in diseases and cancers

Overexpression of Programmed Death Ligand 1 in Dendritic Cells Inhibits Allogeneic Lymphocyte Activation in Mice

CTLA-4 expression by B-1a B cells is essential for immune tolerance

Preventing abnormal NF-κB activation and autoimmunity by Otub1-mediated p100 stabilization

Regulation of T Cell Function by the Ubiquitin-Specific Protease USP9X Via Modulating the Carma1-Bcl10-Malt1 Complex.

Protein phosphatase 6 (Pp6) is crucial for regulatory T cell function and stability in autoimmunity

Mechanism study of ubiquitination in T cell development and autoimmune disease

CMIP is a negative regulator of T cell signaling

The histone lysine methyltransferase MLL1 regulates the activation and functional specialization of regulatory T cells